Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Document And Entity Information

v3.19.2
Document And Entity Information
12 Months Ended
Mar. 31, 2019
shares
Document Information [Line Items]  
Entity Registrant Name Acasti Pharma Inc.
Entity Central Index Key 0001444192
Trading Symbol acst
Current Fiscal Year End Date --03-31
Entity Filer Category Non-accelerated Filer
Entity Current Reporting Status Yes
Entity Voluntary Filers No
Entity Well-known Seasoned Issuer No
Entity Emerging Growth Company false
Entity Common Stock, Shares Outstanding (in shares) 78,132,734
Document Type 20-F
Document Period End Date Mar. 31, 2019
Document Fiscal Year Focus 2019
Document Fiscal Period Focus FY
Amendment Flag false
Entity Shell Company false